Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Curve type (GR values) Curve type (relative cell counts) Experiment name Number of concentrations Cell doublings (DMSO control) GR50 GRmax GR_AOC GEC50 GRinf Hill slope (GR values) R-squared sigmoid fit (GR values) P-value sigmoid fit (GR values) R-squared flat fit (GR values) IC50 Emax AUC EC50 Einf Hill slope (relative cell counts) R-squared sigmoid fit (relative cell counts) P-value sigmoid fit (relative cell counts) R-squared flat fit (relative cell counts)
Hs 578T Torin2 2
sigmoid
sigmoid
Hs578T Torin2 2
8 2.528
0.0153
-0.467
0.778
0.112
-0.771
0.47
0.986
2.55e-06
NA
0.0122
0.0353
0.352
0.0109
0.036
0.668
0.984
4.09e-06
NA
Hs 578T Omipalisib 1
sigmoid
sigmoid
Hs578T omipalisib 1
8 2.079
0.00552
-0.546
0.842
0.17
-1.0
0.321
0.98
8.1e-06
NA
0.0079
0.0459
0.351
0.0079
0.0
0.369
0.984
4.12e-06
NA
HCC70 Omipalisib 1 72
sigmoid
sigmoid
HCC70 omipalisib 0 1 72
8 1.358
0.00496
-0.785
1.14
0.0157
-0.775
0.812
0.989
1.34e-06
NA
0.0123
0.0486
0.349
0.011
0.0462
0.833
0.984
3.73e-06
NA
BT-20 Torin2 2 72
sigmoid
sigmoid
BT20 Torin2 0 2 72
8 1.733
0.00315
-0.761
0.992
0.0484
-0.95
0.389
0.949
0.000131
NA
0.00804
0.0252
0.336
0.00642
0.0613
0.583
0.974
1.77e-05
NA
BT-20 Omipalisib 1 72
sigmoid
sigmoid
BT20 omipalisib 0 1 72
8 2.078
0.00617
-0.729
0.985
0.0283
-0.739
0.596
0.97
2.83e-05
NA
0.00781
0.0157
0.306
0.00685
0.0597
0.96
0.988
1.57e-06
NA
BT-20 Omipalisib 2 72
sigmoid
sigmoid
BT20 omipalisib 0 2 72
8 1.717
0.00324
-0.799
1.1
0.00361
-0.354
4.99
0.808
0.00704
NA
0.00518
0.0194
0.291
0.00429
0.111
1.34
0.968
3.16e-05
NA
BT-20 Omipalisib 3 72
sigmoid
sigmoid
BT20 omipalisib 0 3 72
8 2.586
0.00689
-0.587
0.893
0.044
-0.714
0.478
0.958
7.32e-05
NA
0.00572
0.017
0.281
0.00491
0.0669
0.945
0.983
4.7e-06
NA